We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
+0.48%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$263M
AUM Growth
+$7.9M
Cap. Flow
+$8.82M
Cap. Flow %
3.36%
Top 10 Hldgs %
45.52%
Holding
58
New
24
Increased
7
Reduced
13
Closed
12

Top Buys

Rank Stock Value
1
ARLZ
Aralez Pharmaceuticals Inc.
ARLZ
+$10.1M
2
SGI
Somnigroup International
SGI
+$8.5M
3
THC icon
Tenet Healthcare
THC
+$6.74M
4
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$6.47M
5
ENTA icon
Enanta Pharmaceuticals
ENTA
+$6.28M

Top Sells

Rank Stock Value
1
XNPT
XENOPORT, INC.
XNPT
+$12.8M
2
AVTA
Avantax, Inc. Common Stock
AVTA
+$11.1M
3
TVTY
Tivity Health, Inc. Common Stock
TVTY
+$8.48M
4
VNDA icon
Vanda Pharmaceuticals
VNDA
+$7.75M
5
TBPH icon
Theravance Biopharma
TBPH
+$7.52M

Sector Composition

Rank Sector Weight
1 Healthcare 38.23%
2 Consumer Discretionary 24.75%
3 Consumer Staples 7.97%
4 Financials 1.97%
5 Communication Services 1.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EXPR
51
DELISTED
Express, Inc.
EXPR
– –
-5,400
Closed -$2.31M
TVTY
52
DELISTED
Tivity Health, Inc. Common Stock
TVTY
– –
-840,000
Closed -$8.48M
ARRY
53
DELISTED
Array Biopharma Inc
ARRY
– –
-2,000,000
Closed -$5.9M
SPNC
54
DELISTED
Spectranetics Corp
SPNC
– –
-172,000
Closed -$2.5M
PTX
55
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
– –
-58,200
Closed -$611K
RLOC
56
DELISTED
REACHLOCAL INC COM STK (DE)
RLOC
– –
-925,000
Closed -$1.66M
XNPT
57
DELISTED
XENOPORT, INC.
XNPT
– –
-2,846,000
Closed -$12.8M
1 2
3

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
DWM
Diversify Wealth Management Sandy, Utah $5.61B AUM 19.63% 1-Year Est. Return
DCP
DSM Capital Partners Palm Beach Gardens, Florida $5.66B AUM 27.45% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
AIM
Alphinity Investment Management Sydney, Australia $5.68B AUM 26.72% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return

Armistice Capital's Q2 2016 Portfolio in Review

As of Q2 2016, Armistice Capital held 58 positions worth $263M, up 3.1% from $255M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Armistice Capital deployed $8.82M of net new capital in Q2 2016, opening 24 new positions and adding to 7 existing holdings. Its largest new stake was Aralez Pharmaceuticals Inc.: 2,664,000 shares worth $8.79M.

By sector, the portfolio is most concentrated in Healthcare at 38% of assets, up from 38% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.

On the sell side, the largest reduction was Avantax, Inc. Common Stock, an estimated $11.1M trimmed.

  • Armistice Capital's largest Q2 2016 buy was Aralez Pharmaceuticals Inc.: 2,664,000 shares worth $8.79M.
  • Armistice Capital added most to Tailored Brands, Inc. in Q2 2016, an estimated $4.26M increase.
  • Armistice Capital's biggest Q2 2016 reduction was Avantax, Inc. Common Stock, cutting an estimated $11.1M.
  • Armistice Capital fully exited XENOPORT, INC. in Q2 2016, selling an estimated $12.8M.
  • Armistice Capital's ten largest holdings make up 46% of its $263M portfolio in Q2 2016.
  • Armistice Capital opened 24 new positions and closed 12 in Q2 2016.
  • Armistice Capital's portfolio value rose 3.1% quarter-over-quarter to $263M.

Based on Armistice Capital's 13F filing for Q2 2016, filed 15 Aug 2016.